Literature DB >> 27534672

The γ-glutamyl transpeptidase to platelet ratio (GPR) in HBV patients: just adding up?

Leonardo L Schiavon1, Janaína L Narciso-Schiavon1, Maria Lucia G Ferraz2, Antonio E B Silva2, Roberto J Carvalho-Filho2.   

Abstract

Entities:  

Keywords:  CIRRHOSIS; HEPATIC FIBROSIS; HEPATITIS B

Mesh：

Substances：

Year:  2016        PMID： 27534672     DOI： 10.1136/gutjnl-2016-312658

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  11 in total

1.  Aspartate transaminase to platelet ratio index and gamma-glutamyl transpeptidase-to-platelet ratio outweigh fibrosis index based on four factors and red cell distribution width-platelet ratio in diagnosing liver fibrosis and inflammation in chronic hepatitis B.

Authors:  Xiaojuan Wu; Bei Cai; Zhenzhen Su; Yamei Li; Jin Xu; Rong Deng; Lanlan Wang
Journal:  J Clin Lab Anal       Date:  2017-12-18       Impact factor: 2.352

2.  Artificial Neural Network Model for Liver Cirrhosis Diagnosis in Patients with Hepatitis B Virus-Related Hepatocellular Carcinoma.

Authors:  Rong-Yun Mai; Jie Zeng; Yi-Shuai Mo; Rong Liang; Yan Lin; Su-Su Wu; Xue-Min Piao; Xing Gao; Guo-Bin Wu; Le-Qun Li; Jia-Zhou Ye
Journal:  Ther Clin Risk Manag       Date:  2020-07-17       Impact factor: 2.423

3.  Gamma-glutamyl-transpeptidase to platelet ratio is not superior to APRI,FIB-4 and RPR for diagnosing liver fibrosis in CHB patients in China.

Authors:  Rui Huang; Guiyang Wang; Chen Tian; Yong Liu; Bei Jia; Jian Wang; Yue Yang; Yang Li; Zhenhua Sun; Xiaomin Yan; Juan Xia; Yali Xiong; Peixin Song; Zhaoping Zhang; Weimao Ding; Chao Wu
Journal:  Sci Rep       Date:  2017-08-17       Impact factor: 4.379

4.  Are non-invasive fibrosis markers for chronic hepatitis B reliable in sub-Saharan Africa?

Authors:  Hailemichael Desalegn; Hanna Aberra; Nega Berhe; Svein G Gundersen; Asgeir Johannessen
Journal:  Liver Int       Date:  2017-03-23       Impact factor: 5.828

5.  A novel predictive model using routinely clinical parameters to predict liver fibrosis in patients with chronic hepatitis B.

Authors:  Jian Wang; Xiaomin Yan; Yue Yang; Haiyan Chang; Bei Jia; Xiang-An Zhao; Guangmei Chen; Juan Xia; Yong Liu; Yuxin Chen; Guiyang Wang; Li Wang; Zhaoping Zhang; Weimao Ding; Rui Huang; Chao Wu
Journal:  Oncotarget       Date:  2017-07-22

6.  The gamma-glutamyl transpeptidase to platelet ratio for non-invasive assessment of liver fibrosis in patients with chronic hepatitis B and non-alcoholic fatty liver disease.

Authors:  Qiang Li; Chuan Lu; Weixia Li; Yuxian Huang; Liang Chen
Journal:  Oncotarget       Date:  2017-04-25

7.  A Noninvasive Score to Predict Liver Fibrosis in HBeAg-Positive Hepatitis B Patients with Normal or Minimally Elevated Alanine Aminotransferase Levels.

Authors:  Yanping Chen; Yanping Li; Na Li; Xiude Fan; Chunyan Li; Pingping Zhang; Qunying Han; Zhengwen Liu
Journal:  Dis Markers       Date:  2018-10-14       Impact factor: 3.434

8.  Declining diagnostic accuracy of non-invasive fibrosis tests is associated with elevated alanine aminotransferase in chronic hepatitis B.

Authors:  Lin Wang; Yao-Xin Fan; Xiao-Guang Dou
Journal:  World J Clin Cases       Date:  2018-10-26       Impact factor: 1.337

9.  Gamma-glutamyl Transpeptidase to Platelet Ratio Predicts Liver Injury in Hepatitis B e Antigen-negative Chronic Hepatitis B Patients With Normal Alanine Aminotransferase.

Authors:  Xiang-An Zhao; Jian Wang; Jie Wei; Jiacheng Liu; Guangmei Chen; Li Wang; Guiyang Wang; Juan Xia; Weihua Wu; Shengxia Yin; Xin Tong; Xiaomin Yan; Weimao Ding; Xiaoxing Xiang; Rui Huang; Chao Wu
Journal:  J Clin Transl Hepatol       Date:  2021-07-14

10.  Value of gamma-glutamyltranspeptidase-to-platelet ratio in diagnosis of hepatic fibrosis in patients with chronic hepatitis B.

Authors:  Yan-Chao Hu; Hao Liu; Xiao-Yan Liu; Li-Na Ma; Yu-Hua Guan; Xia Luo; Xiang-Chun Ding
Journal:  World J Gastroenterol       Date:  2017-11-07       Impact factor: 5.742
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.